According to both the American Cancer Society and the World Health Organization, talcum powder is potentially carcinogenic and cancer-causing. The use of talcum powder can be linked to several types of cancers, with special emphasis placed on ovarian cancer. If you or a loved one has received a cancer diagnosis, and you believe it may be due to talcum powder use, please know that there are other people like you who are also experiencing this devastation and that we want to hear from you.
What Is Talcum Powder?
Talcum powder is the loose powdery form of talc, a clay mineral composed of hydrous magnesium silicate. Consumers know it as Baby Powder or Shower to Shower, both manufactured by Johnson & Johnson.
While Johnson & Johnson has known about the risks of talcum powder for more than 40 years, they have done nothing to protect consumers. They have continued to produce, market and sell the products.
Women have purchased Baby Powder and Shower to Shower for decades. Many women have used talcum powder daily. A woman who uses talcum powder — specifically in her genital region — has an increased risk of developing ovarian cancer. The miniscule talc particles can travel through her vagina, uterus and fallopian tubes to her ovaries. Cancer patients and their families who have suffered needlessly due to Johnson & Johnson's negligence deserve committed, experienced and successful legal counsel.
We are currently investigating claims associated with talcum powder use. If you have reason to believe that you have a claim, we would like to speak with you.
We Would Like To Help You. Call A Lawyer In Nashville, Tennessee, For A Free Consultation.
If you or a loved one has suffered in any way due to the use of talcum powder, including a cancer diagnosis, you may be eligible to file a lawsuit against Johnson & Johnson, the manufacturer of talcum powder products. Call our attorneys today to learn more in a free initial consultation. We can be reached locally at 615-338-6177 or toll free at 866-468-6603. We can also be contacted online.